AF
IMVT icon

Advisornet Financial’s Immunovant IMVT Stock Holding History

Advisornet Financial’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.9K Hold
671
– – ﹤0.01% 1312
2026
Q1 		$16.7K Buy
671
+99
+17% +$2.56K ﹤0.01% 1391
2025
Q4 		$14.5K Buy
572
+135
+31% +$3.01K ﹤0.01% 1428
2025
Q3 		$7.04K Hold
437
– – ﹤0.01% 1620
2025
Q2 		$6.99K Buy
+437
New +$6.61K ﹤0.01% 1585

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Advisornet Financial's IMVT Position: Q2 2026 in Review

Advisornet Financial held its Immunovant (IMVT) position steady in Q2 2026 at 671 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1312.

Advisornet Financial first reported a position in IMVT in Q2 2025 and has held it in 5 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Advisornet Financial held 671 shares of Immunovant worth $25.9K as of Q2 2026.
  • Advisornet Financial left its Immunovant share count unchanged in Q2 2026.
  • Immunovant made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1312 holding.
  • Advisornet Financial first reported a position in Immunovant in Q2 2025 and has held it in 5 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.